| Date | Name | Title | Action | No Shares | Price Per Share |
|---|---|---|---|---|---|
Insider Transactions For HCA | |||||
| 2025-11-14 | Hazen, Samuel N | Director, CEO | Sold | 14830 | $0.00 |
| 2025-11-05 | Marks, Mike A | EVP and CFO | Sold | 165 | $0.00 |
| 2025-11-05 | Mcalevey, Michael R | EVP & Chief Legal & Admin Off. | Sold | 3892 | $473.79 |
| 2025-11-03 | Marks, Mike A | EVP and CFO | Purchased | 165 | $0.00 |
| 2025-11-03 | Mcalevey, Michael R | EVP & Chief Legal & Admin Off. | Purchased | 13170 | $236.61 |
| 2025-11-03 | Mcalevey, Michael R | EVP & Chief Legal & Admin Off. | Sold | 9278 | $461.56 |
| 2025-11-03 | Mcalevey, Michael R | EVP & Chief Legal & Admin Off. | Sold | 13170 | $0.00 |
| 2025-11-03 | Marks, Mike A | EVP and CFO | Sold | 165 | $0.00 |
| 2025-10-31 | Hazen, Samuel N | Director, CEO | Sold | 28173 | $459.68 |
| 2025-10-31 | Hazen, Samuel N | Director, CEO | Purchased | 58050 | $69.58 |
| 2025-10-31 | Hazen, Samuel N | Director, CEO | Sold | 58050 | $0.00 |
| 2025-09-08 | Cuffe, Michael S. | EVP and Chief Clinical Officer | Sold | 3836 | $418.84 |
| 2025-09-04 | Cuffe, Michael S. | EVP and Chief Clinical Officer | Sold | 10920 | $0.00 |
| 2025-09-04 | Cuffe, Michael S. | EVP and Chief Clinical Officer | Purchased | 10920 | $173.12 |
| 2025-09-04 | Cuffe, Michael S. | EVP and Chief Clinical Officer | Sold | 7084 | $411.59 |
| 2025-07-29 | Chidsey, John | Director | Purchased | 496 | $0.00 |
| 2025-05-13 | Foster, Jon M | EVP and COO | Sold | 15925 | $367.20 |
| 2025-05-13 | Hazen, Samuel N | Director, CEO | Sold | 90076 | $0.00 |
| 2025-05-13 | Hazen, Samuel N | Director, CEO | Purchased | 90076 | $0.00 |
| 2025-05-13 | Foster, Jon M | EVP and COO | Sold | 15698 | $369.32 |